Aktuellt
SENASTE
Redeye provides its initial take on Acarix's Q1 report. The report showed sales below our estimates but a lower-than-expected loss at the EBIT level following good cost control. We expect to make minor adjustments to our forecasts following the report.
LÄS MER
